Cargando…
Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome
Acute respiratory distress syndrome (ARDS) is a multifaced disease characterized by the acute onset of hypoxemia, worsened pulmonary compliance, and noncardiogenic pulmonary edema. Despite over five decades of research, specific treatments for established ARDS are still lacking. MSC-based therapies...
Autores principales: | Han, Jibin, Li, Yanmin, Li, Yuanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893276/ https://www.ncbi.nlm.nih.gov/pubmed/31885615 http://dx.doi.org/10.1155/2019/5432134 |
Ejemplares similares
-
Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
por: Han, Jibin, et al.
Publicado: (2019) -
Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome
por: Hayes, Mairead, et al.
Publicado: (2012) -
Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome
por: Horie, Shahd, et al.
Publicado: (2016) -
Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics
por: Qin, Hua, et al.
Publicado: (2020) -
Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome
por: Wang, Yan-Yang, et al.
Publicado: (2013)